Cargando…

Proteomics of epicardial adipose tissue in patients with heart failure

Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot closely linked to the pathogenesis of heart failure (HF). But the molecular signatures related to the mechanism of HF have not been systematically explored. Here, we present comprehensive proteomic analysis of EAT in HF pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lei, Guo, Zongsheng, Wang, Pan, Zheng, Meili, Yang, Xiaoyan, Liu, Ye, Ma, Zheng, Chen, Mulei, Yang, Xinchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933327/
https://www.ncbi.nlm.nih.gov/pubmed/31670476
http://dx.doi.org/10.1111/jcmm.14758
_version_ 1783483187129745408
author Zhao, Lei
Guo, Zongsheng
Wang, Pan
Zheng, Meili
Yang, Xiaoyan
Liu, Ye
Ma, Zheng
Chen, Mulei
Yang, Xinchun
author_facet Zhao, Lei
Guo, Zongsheng
Wang, Pan
Zheng, Meili
Yang, Xiaoyan
Liu, Ye
Ma, Zheng
Chen, Mulei
Yang, Xinchun
author_sort Zhao, Lei
collection PubMed
description Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot closely linked to the pathogenesis of heart failure (HF). But the molecular signatures related to the mechanism of HF have not been systematically explored. Here, we present comprehensive proteomic analysis of EAT in HF patients and non‐HF patients as controls. A total of 771 proteins were identified in liquid chromatography‐tandem mass spectrometry experiments. Amongst them, 17 increased in abundance in HF and seven decreased. They were involved in HF‐related processes including inflammation and oxidative stress response and lipid metabolism. Of these proteins, serine proteinase inhibitor A3 (Serpina3) levels in EAT were highly up‐regulated in HF, with HF/non‐HF ratio of 4.63 (P = .0047). Gene expression of Serpina3 via quantitative polymerase chain reaction was significantly increased in the HF group. ELISA analysis confirmed a significant increase in circulating plasma Serpina3 levels in the HF group (P = .004). In summary, for the first time, we describe that parts of EAT proteome may be reactive and work as modulators of HF. Our profiling provides a comprehensive basis for linking EAT with pathogenesis of HF. Understanding the role of EAT may offer new insights into the treatment of HF.
format Online
Article
Text
id pubmed-6933327
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69333272020-01-01 Proteomics of epicardial adipose tissue in patients with heart failure Zhao, Lei Guo, Zongsheng Wang, Pan Zheng, Meili Yang, Xiaoyan Liu, Ye Ma, Zheng Chen, Mulei Yang, Xinchun J Cell Mol Med Original Articles Epicardial adipose tissue (EAT) is a metabolically active visceral fat depot closely linked to the pathogenesis of heart failure (HF). But the molecular signatures related to the mechanism of HF have not been systematically explored. Here, we present comprehensive proteomic analysis of EAT in HF patients and non‐HF patients as controls. A total of 771 proteins were identified in liquid chromatography‐tandem mass spectrometry experiments. Amongst them, 17 increased in abundance in HF and seven decreased. They were involved in HF‐related processes including inflammation and oxidative stress response and lipid metabolism. Of these proteins, serine proteinase inhibitor A3 (Serpina3) levels in EAT were highly up‐regulated in HF, with HF/non‐HF ratio of 4.63 (P = .0047). Gene expression of Serpina3 via quantitative polymerase chain reaction was significantly increased in the HF group. ELISA analysis confirmed a significant increase in circulating plasma Serpina3 levels in the HF group (P = .004). In summary, for the first time, we describe that parts of EAT proteome may be reactive and work as modulators of HF. Our profiling provides a comprehensive basis for linking EAT with pathogenesis of HF. Understanding the role of EAT may offer new insights into the treatment of HF. John Wiley and Sons Inc. 2019-10-31 2020-01 /pmc/articles/PMC6933327/ /pubmed/31670476 http://dx.doi.org/10.1111/jcmm.14758 Text en © 2019 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhao, Lei
Guo, Zongsheng
Wang, Pan
Zheng, Meili
Yang, Xiaoyan
Liu, Ye
Ma, Zheng
Chen, Mulei
Yang, Xinchun
Proteomics of epicardial adipose tissue in patients with heart failure
title Proteomics of epicardial adipose tissue in patients with heart failure
title_full Proteomics of epicardial adipose tissue in patients with heart failure
title_fullStr Proteomics of epicardial adipose tissue in patients with heart failure
title_full_unstemmed Proteomics of epicardial adipose tissue in patients with heart failure
title_short Proteomics of epicardial adipose tissue in patients with heart failure
title_sort proteomics of epicardial adipose tissue in patients with heart failure
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6933327/
https://www.ncbi.nlm.nih.gov/pubmed/31670476
http://dx.doi.org/10.1111/jcmm.14758
work_keys_str_mv AT zhaolei proteomicsofepicardialadiposetissueinpatientswithheartfailure
AT guozongsheng proteomicsofepicardialadiposetissueinpatientswithheartfailure
AT wangpan proteomicsofepicardialadiposetissueinpatientswithheartfailure
AT zhengmeili proteomicsofepicardialadiposetissueinpatientswithheartfailure
AT yangxiaoyan proteomicsofepicardialadiposetissueinpatientswithheartfailure
AT liuye proteomicsofepicardialadiposetissueinpatientswithheartfailure
AT mazheng proteomicsofepicardialadiposetissueinpatientswithheartfailure
AT chenmulei proteomicsofepicardialadiposetissueinpatientswithheartfailure
AT yangxinchun proteomicsofepicardialadiposetissueinpatientswithheartfailure